Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Job of a Migration Legal advisor: How They Can Help You - 2How color-changing, bacteria-infused spacesuits could help keep future astronauts safe from space radiation
- 3Poland open to German troops to help secure Ukraine ceasefire
- 4Survey: Protected And Versatile Men's Razor
- 5How to watch ‘The Traitors’ U.K. Season 4 from the U.S.
- Excelling at Cash The board: A Manual for Monetary Essentials
- A photographer's journey to capture a blood moon rising over the South China Sea. 'It was an incredible moment'
- How to see the Ursids, the final meteor shower of 2025
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Unwinding History's Secrets: Looking for the Response to Antiquated Human advancements
- How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
- Where should we send a real 'Hail Mary' spacecraft? A new study has the answers
